Skip to content
February 27, 2020 | Vensana in the News
Vensana—Is Medtech Investing on the Rebound?
Novel FDA PMA & de novo 510k approvals
U.S. Commercial Product Launches
Level I Clinical Trials
Exits by IPO or M&A
CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS
Ready to change healthcare together? Contact us to arrange for investments in development and commercial stage companies.
Get in Touch